BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 12853341)

  • 1. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of squamous cell carcinoma of the head and neck.
    Pivot X;
    Ann Oncol; 2003 Jul; 14(7):1014-5. PubMed ID: 12853341
    [No Abstract]   [Full Text] [Related]  

  • 2. Squamous cell carcinoma of the head and neck: ESMO clinical recommendations for diagnosis, treatment and follow-up.
    ; Pivot X; Villanueva C
    Ann Oncol; 2007 Apr; 18 Suppl 2():ii65-6. PubMed ID: 17491053
    [No Abstract]   [Full Text] [Related]  

  • 3. Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Grégoire V; Lefebvre JL; Licitra L; Felip E;
    Ann Oncol; 2010 May; 21 Suppl 5():v184-6. PubMed ID: 20555077
    [No Abstract]   [Full Text] [Related]  

  • 4. Squamous cell carcinoma of the head and neck: ESMO clinical Recommendations for diagnosis, treatment and follow-up.
    Pivot X; Felip E;
    Ann Oncol; 2008 May; 19 Suppl 2():ii79-80. PubMed ID: 18456779
    [No Abstract]   [Full Text] [Related]  

  • 5. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of squamous cell carcinoma of the head and neck (SCCHN).
    Pivot X; Kataja VV; Jelic S;
    Ann Oncol; 2005; 16 Suppl 1():i62-3. PubMed ID: 15888759
    [No Abstract]   [Full Text] [Related]  

  • 6. Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis.
    Iyer NG; Tan DS; Tan VK; Wang W; Hwang J; Tan NC; Sivanandan R; Tan HK; Lim WT; Ang MK; Wee J; Soo KC; Tan EH
    Cancer; 2015 May; 121(10):1599-607. PubMed ID: 25639864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and treatment of the N0 neck of carcinomas of the upper aerodigestive tract. Report of an international symposium, Göttingen, Germany, 1992.
    Steiner W; Hommerich CP
    Eur Arch Otorhinolaryngol; 1993; 250(8):450-6. PubMed ID: 8129924
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of squamous cell carcinoma of the head and neck: updated European treatment recommendations.
    Ramos M; Benavente S; Giralt J
    Expert Rev Anticancer Ther; 2010 Mar; 10(3):339-44. PubMed ID: 20214515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organ preservation: II.
    Hanna EY
    Curr Oncol Rep; 2001 Jan; 3(1):44. PubMed ID: 15849884
    [No Abstract]   [Full Text] [Related]  

  • 10. Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment.
    Marur S; Forastiere AA
    Mayo Clin Proc; 2016 Mar; 91(3):386-96. PubMed ID: 26944243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer.
    Argiris A; Stenson KM; Brockstein BE; Mittal BB; Pelzer H; Kies MS; Jayaram P; Portugal L; Wenig BL; Rosen FR; Haraf DJ; Vokes EE
    Head Neck; 2004 May; 26(5):447-55. PubMed ID: 15122662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant treatment for post-operative head and neck squamous cell carcinoma.
    Kiyota N; Tahara M; Fujii M
    Jpn J Clin Oncol; 2015 Jan; 45(1):2-6. PubMed ID: 25411434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent radiation chemotherapy for locally advanced head and neck carcinoma: are we addressing burning subjects?
    Ang KK
    J Clin Oncol; 2004 Dec; 22(23):4657-9. PubMed ID: 15534361
    [No Abstract]   [Full Text] [Related]  

  • 14. Systematic review and individual patient data analysis of pediatric head and neck squamous cell carcinoma: An analysis of 217 cases.
    Bhanu Prasad V; Mallick S; Upadhyay AD; Rath GK
    Int J Pediatr Otorhinolaryngol; 2017 Jan; 92():75-81. PubMed ID: 28012539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of squamous cell carcinoma of external auditory canal: A tertiary cancer centre experience.
    Gandhi AK; Roy S; Biswas A; Raza MW; Saxena T; Bhasker S; Sharma A; Thakar A; Mohanti BK
    Auris Nasus Larynx; 2016 Feb; 43(1):45-9. PubMed ID: 26165629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Outcome and prognostic factors of 125 loco-regionally advanced head and neck squamous cell carcinoma treated with multi-modality treatment].
    Qian W; Zhu G; Ji Q; Guo Y; Wang Y; Wang Y
    Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):217-22. PubMed ID: 24785284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Colombo N; Carinelli S; Colombo A; Marini C; Rollo D; Sessa C;
    Ann Oncol; 2012 Oct; 23 Suppl 7():vii27-32. PubMed ID: 22997451
    [No Abstract]   [Full Text] [Related]  

  • 18. Paclitaxel, carboplatin, and concomitant radiotherapy for resected patients with high risk head and neck cancer.
    Agulnik M; Rhee EN; Yao M; Mundt AJ; Feldman LE
    J Chemother; 2005 Apr; 17(2):237-41. PubMed ID: 15920912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I trial and pharmacokinetics of escalating doses of paclitaxel and concurrent hyperfractionated radiotherapy with or without amifostine in patients with advanced head and neck carcinoma.
    Amrein PC; Clark JR; Supko JG; Fabian RL; Wang CC; Colevas AD; Posner MR; Deschler DG; Rocco JW; Finkelstein DM; McIntyre JF
    Cancer; 2005 Oct; 104(7):1418-27. PubMed ID: 16116597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of cutaneous malignant melanoma.
    Jost LM;
    Ann Oncol; 2003 Jul; 14(7):1012-3. PubMed ID: 12853340
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.